Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens

被引：0
|
作者：
Sarah M. Kashanian
Noa G. Holtzman
Ciera L. Patzke
Jonathan Cornu
Alison Duffy
Madhurima Koka
Sandrine Niyongere
Vu H. Duong
Maria R. Baer
Jummai Apata
Farin Kamangar
Ashkan Emadi
机构：
[1] University of Maryland School of Medicine,Department of Medicine
[2] National Cancer Institute,Immune Deficiency Cellular Therapy Program, Center for Cancer Research
[3] National Institutes of Health,Greenebaum Comprehensive Cancer Center
[4] University of Maryland School of Medicine,Department of Pharmacy
[5] University of Maryland Medical Center,Department of Pathology
[6] University of Maryland School of Pharmacy,Center for Urban Health Disparities Research and Innovation
[7] University of Maryland School of Medicine,Department of Biology, School of Computer, Mathematical, and Natural Sciences
[8] Morgan State University,Department of Pharmacology
[9] Morgan State University,undefined
[10] University of Maryland School of Medicine,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2021年 / 87卷
关键词：
Acute lymphoblastic leukemia; Pegylated-asparaginase; Pegaspargase; ALL; Venous thromboembolism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：817 / 826
页数：9
相关论文
共 50 条
  • [1] Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens
    Kashanian, Sarah M.
    Holtzman, Noa G.
    Patzke, Ciera L.
    Cornu, Jonathan
    Duffy, Alison
    Koka, Madhurima
    Niyongere, Sandrine
    Duong, Vu H.
    Baer, Maria R.
    Apata, Jummai
    Kamangar, Farin
    Emadi, Ashkan
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (06) : 817 - 826
  • [2] Antithrombin supplementation did not impact the incidence of pegylated asparaginase-induced venous thromboembolism in adults with acute lymphoblastic leukemia
    Chen, Jason
    Ngo, Dat
    Aldoss, Ibrahim
    Shayani, Sepideh
    Tsai, Ni-Chun
    Pullarkat, Vinod
    LEUKEMIA & LYMPHOMA, 2019, 60 (05) : 1187 - 1192
  • [3] Comment on 'asparaginase activities during intensified treatment with pegylated E. coli asparaginase in adults with newly diagnosed acute lymphoblastic leukemia'
    Tong, Wing H.
    LEUKEMIA & LYMPHOMA, 2022, 63 (02) : 509 - 510
  • [4] Asparaginase activities during intensified treatment with pegylated E. coli asparaginase in adults with newly-diagnosed acute lymphoblastic leukemia
    Lanvers-Kaminsky, Claudia
    Niemann, Andreas
    Eveslage, Maria
    Beck, Joachim
    Koehnke, Thomas
    Martin, Sonja
    de Wit, Maike
    Spriewald, Bernd
    Hauspurg, Holger
    Hoelzer, Dieter
    Boos, Joachim
    Goekbuget, Nicola
    LEUKEMIA & LYMPHOMA, 2020, 61 (01) : 138 - 145
  • [5] Thromboembolism in adults with acute lymphoblastic leukemia during induction with L-asparaginase-containing multi-agent regimens: Incidence, risk factors, and possible role of antithrombin
    Elliott, MA
    Wolf, RC
    Hook, CC
    Pruthi, RK
    Heit, JA
    Letendre, LL
    Tefferi, A
    Kaufmann, SH
    Mesa, RA
    Litzow, MR
    LEUKEMIA & LYMPHOMA, 2004, 45 (08) : 1545 - 1549
  • [6] Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols)
    Mauz-Körholz, C
    Junker, R
    Göbel, U
    Nowak-Göttl, U
    THROMBOSIS AND HAEMOSTASIS, 2000, 83 (06) : 840 - 843
  • [7] Erwinia Asparaginase After Allergy to E. coli Asparaginase in Children With Acute Lymphoblastic Leukemia
    Vrooman, Lynda M.
    Supko, Jeffrey G.
    Neuberg, Donna S.
    Asselin, Barbara L.
    Athale, Uma H.
    Clavell, Luis
    Kelly, Kara M.
    Laverdiere, Caroline
    Michon, Bruno
    Schorin, Marshall
    Cohen, Harvey J.
    Sallan, Stephen E.
    Silverman, Lewis B.
    PEDIATRIC BLOOD & CANCER, 2010, 54 (02) : 199 - 205
  • [8] Impact of Prophylactic Fresh Frozen Plasma On Venous Thromboembolism in Adults Treated for Acute Lymphoblastic Leukemia Receiving Asparaginase
    Lauw, Mandy N.
    Van der Holt, Bronno
    Middeldorp, Saskia
    Meijers, Joost C. M.
    Biemond, Bart J.
    BLOOD, 2011, 118 (21) : 1435 - 1436
  • [9] Incidence, characteristics, and risk factors of venous thromboembolism in adolescent and young adult acute lymphoblastic leukemia patients receiving peg-asparaginase.
    Underwood, Brynne
    Zhao, Qiuhong
    Walker, Alison R.
    Mims, Alice S.
    Vasu, Sumithira
    Behbehani, Gregory
    Blachly, James Stewart
    Larkin, Karilyn T. M.
    Wang, Tzu-Fei
    Bhatnagar, Bhavana
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia
    MH Woo
    LJ Hak
    MC Storm
    WE Evans
    JT Sandlund
    GK Rivera
    B Wang
    C-H Pui
    MV Relling
    Leukemia, 1998, 12 : 1527 - 1533
12345